Latest News

NantKwest to Host 4th Annual Investor/Analyst Day Highlighting Industry Leading R&D and Clinical Programs

CULVER CITY, Calif.–(BUSINESS WIRE)–NantKwest (Nasdaq:NK), a pioneering, next generation, clinical-stage immunotherapy company focused on harnessing the unique power of the human immune system using natural killer (NK) cells to treat cancer, infectious diseases and inflammatory diseases today announced that the company will be hosting an Investor/Analyst Day on Tuesday, January 8, 2019 in San Francisco, California. NantKwest will be sharing with analysts and investors a review of the company’

Source link

Related posts

CORRECTING and REPLACING Health Net Provides Assistance to Ferguson Fire Evacuees in Mariposa County


Four Confirmed Mild-Types of Adenovirus Cases at Voorhees Pediatric Facility under Control and No Further Outbreaks Reported


Persistent sore throat could be larynx cancer warning


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy